open access

Vol 10, No 4 (2016)
Review paper
Published online: 2017-05-19
Get Citation

An overview of pharmacist roles in palliative care: a worldwide comparison

Natalia Krzyżaniak1, Iga Pawłowska2, Beata Bajorek1
Medycyna Paliatywna w Praktyce 2016;10(4):160-173.
Affiliations
  1. University of Technology Sydney, Australia
  2. Department of Histology, Medical University of Gdansk, Gdansk

open access

Vol 10, No 4 (2016)
Review paper
Published online: 2017-05-19

Abstract

Background. In order to fulfil the complex needs of terminally ill patients, palliative care demands an in­ter-professional collaborative network, including doctors, nurses, dieticians and social workers. Pharmacists in particular are essential members of this team, given the level of reliance on medications in this setting. The purpose of this review is to identify roles and services performed by palliative care pharmacists in dedicated palliative care settings worldwide and to map these findings against the Advanced Pharmacy Practice Framework.

Material and methods. Quasi-systematic review. Search strategy: Google Scholar, Medline/PubMed, Scopus and Embase were searched utilizing selected MeSH terms.

Results. A total of 24 sources of information were included in the review. This literature was collected from a range of countries, predominantly from the USA, UK and Australia with singular reports from Mexico, Japan, Qatar, Canada, Poland and Sweden. The literature identifies that pharmacist roles in palliative care are varied and quite extensive. Roles that were specifically tailored to the palliative setting included: aggressive symptom management (in particular pain control), deprescribing, advising on the use of complementary and alternative therapies, extemporaneous compounding of non-standard dosage forms and maintaining a timely supply of medications. Pharmacists in the UK, USA, Canada and Australia were found to perform an advanced level of practice (as their reported roles fulfilled the criteria of the majority of the domains in the APPF). However, pharmacists in other countries, in particular Mexico and Poland, did not present such an extensive scope of practice.

Conclusion. The literature identifies that there are differences in the types of palliative pharmacist practice between countries, which may have varying levels of impact upon patient outcomes. As pharmacists can make significant contributions to palliative care, it is important to encourage the benchmarking of practice across different clinical settings and countries to promote a consistent and equitable practice.

Abstract

Background. In order to fulfil the complex needs of terminally ill patients, palliative care demands an in­ter-professional collaborative network, including doctors, nurses, dieticians and social workers. Pharmacists in particular are essential members of this team, given the level of reliance on medications in this setting. The purpose of this review is to identify roles and services performed by palliative care pharmacists in dedicated palliative care settings worldwide and to map these findings against the Advanced Pharmacy Practice Framework.

Material and methods. Quasi-systematic review. Search strategy: Google Scholar, Medline/PubMed, Scopus and Embase were searched utilizing selected MeSH terms.

Results. A total of 24 sources of information were included in the review. This literature was collected from a range of countries, predominantly from the USA, UK and Australia with singular reports from Mexico, Japan, Qatar, Canada, Poland and Sweden. The literature identifies that pharmacist roles in palliative care are varied and quite extensive. Roles that were specifically tailored to the palliative setting included: aggressive symptom management (in particular pain control), deprescribing, advising on the use of complementary and alternative therapies, extemporaneous compounding of non-standard dosage forms and maintaining a timely supply of medications. Pharmacists in the UK, USA, Canada and Australia were found to perform an advanced level of practice (as their reported roles fulfilled the criteria of the majority of the domains in the APPF). However, pharmacists in other countries, in particular Mexico and Poland, did not present such an extensive scope of practice.

Conclusion. The literature identifies that there are differences in the types of palliative pharmacist practice between countries, which may have varying levels of impact upon patient outcomes. As pharmacists can make significant contributions to palliative care, it is important to encourage the benchmarking of practice across different clinical settings and countries to promote a consistent and equitable practice.

Get Citation

Keywords

pharmacist roles, pharmacy services, palliative/hospice care

About this article
Title

An overview of pharmacist roles in palliative care: a worldwide comparison

Journal

Palliative Medicine in Practice

Issue

Vol 10, No 4 (2016)

Article type

Review paper

Pages

160-173

Published online

2017-05-19

Page views

2134

Article views/downloads

1568

Bibliographic record

Medycyna Paliatywna w Praktyce 2016;10(4):160-173.

Keywords

pharmacist roles
pharmacy services
palliative/hospice care

Authors

Natalia Krzyżaniak
Iga Pawłowska
Beata Bajorek

References (47)
  1. WHO Definition of Palliative Care: World Health Organisation.2017. Available from: http://www who int/cancer/palliative/definition/en ([04/01/2017]).
  2. Cortis LJ, McKinnon RA, Anderson C. Palliative Care Is Everyone's Business, Including Pharmacists. American Journal of Pharmaceutical Education. 2013; 77(2): 1–3.
  3. Jiwa M, O'Connor M, Hughes J, et al. The Role of the Pharmacist in the Provision of Palliative Care. Australian Government Department of Health and Ageing. ; 2007.
  4. Radbruch L, Hoffman-Menzel H, Kern M, et al. Hospice pharmaceutical care: the care for the dying. European Journal of Hospital Pharmacy. 2012; 19: 45–8.
  5. Crawford G. Pharmacists needed as part of the palliative care team. Australian J Pharm. 2008; 89: 24.
  6. O'Connor M, Pugh J, Jiwa M, et al. The Palliative Care Interdisciplinary Team: Where Is The Community Pharmacist? Journal of Palliative Medicine. 2011; 14(1): 7–11.
  7. Currow D, Stevenson J, Abernethy A, et al. Prescribing in palliative care as death approaches. Journal of the American Geriatrics Society. 2007; 55(4): 590–5.
  8. Atayee R, Best B, Daniels C. Development of an ambulatory palliative care pharmacist practice. J Palliat Med. 2008; 11(8): 1077–83.
  9. Austwick E, Brown L, Goodyear K, et al. Pharmacist's input into palliative care clinic. Pharm J. 2002; 268(7190): 404–6.
  10. Willson S, Wahler R, Brown J, et al. Impact of Pharmacist Intervention on Clinical Outcomes in the Palliative Care Setting. American Journal of Hospice & Palliative Medicine. 2011; 28(5): 316–20.
  11. Martinez-Martin P, Leentjens AF, de PeC, et al. Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. ; 2015.
  12. Nasser S, Mullan J, Bajorek B. Challenges of older patients’ knowledge about warfarin therapy. Journal of primary care & community health. 2012; 3(1): 65–74.
  13. Rys P, Wladysiuk M, Skrzekowska-Baran I, et al. Review articles, systematic reviews and meta-analyses: which can be trusted? Polskie Archiwum Medycyny Wewnetrznej. 2009; 119(3): 148–56.
  14. Advanced Pharmacy Practice Framework Steering Committee. An Advanced Pharmacy Practice Framework for Australia 2012. http://advancedpharmacypractice.com.au/download/framework/advanced-pharmacy-practice-framework.pdf. ([29/01/2017]).
  15. Austwick E, Brooks D. Role of the palliative care pharmacist: an example from North Derbyshire, UK. Progress in Palliative Care. 2004; 12(1): 2–5.
  16. Barbee Jr J, Kelley S, Andrews J, Harman A. Palliative Care: The Role of the Pharmacist: Pharmacy Times; 2016. http://www.pharmacytimes.com/publications/health-system-edition/2016/november2016/palliative-care-the-pharmacists-role ([29/01/2017]).
  17. Gibbs M. The Contribution of the Clinical Pharmacist in Palliative Care. In: Cherny NI, Fallon M, Kaasa S, Portenoy RK, Currow DC, editors. Oxford Textbook of Palliative Medicine. 5 ed. Oxford: Oxford University Press; 2015. p. : 228–35.
  18. Gilbar P, Stefaniuk K. The role of the pharmacist in palliative care: results of a survey conducted in Australia and Canada. Journal of Palliative Care. 2002; 18(4): 287–92.
  19. Herndon CM, Nee D, Atayee RS, et al. et al.. ASHP Guidelines on the pharmacist's role in palliative and hospice care. Am J Health-Syst Pharm. 2016; 73: 1351–67.
  20. Hussainy SY, Box M, Scholes S. Piloting the role of a pharmacist in a community palliative care multidisciplinary team: an Australian experience. BMC Palliative Care. 2011; 10(16).
  21. McCrate-Protus B, Kimbrel J, Gonzalez J. Clinical pharmacists' partnership with hospices drives an evolution of PBM services. Formulary. 2012; 47: 428–32.
  22. Pruskowski J, Arnold R, Skledar S. Development of a health-system palliative care clinical pharmacist. American Journal of Health-System Pharmacy. 2017; 74(1): e6–e8.
  23. Swetenham K, Rowett D, Stephenson D. Clinical networks influencing policy and practice: the establishment of advanced practice pharmacist roles for specialist palliative care services in South Australia. Australian Health Review. 2014; 38: 238–41.
  24. Walker K. Role of the pharmacist in palliative care. Progress in Palliative Care. 2010; 18(3): 132–9.
  25. Walker K, Scarpaci L, McPherson ML. Fifty reasons to love your palliative care pharmacist. American Journal of Hospice & Palliative Medicine. 2010; 27(8): 511–3.
  26. Dispennette R, Hall L, Elliott D. Activities of palliative care and pain management clinical pharmacists. Am J Health-Syst Pharm. 2015; 72: 999–1000.
  27. Khan J, Gaze S, Tomlin S. The role of the pharmacist in paediatric palliative care. Arch Dis Child. 2016; 101(9): A1–A37.
  28. Hill R. Clinical pharmacy services in a home-based palliative care program. Am J Health-Syst Pharm. 2007; 64: 806–10.
  29. Ise Y, Morita T, Katayama S, et al. The activity of palliative care team pharmacists in designated cancer hospitals: a nationwide survey in Japan. Journal of Pain and Symptom Management. 2014; 47(3): 588–93.
  30. Norrstrom B, Cannerfelt I-B, Frid H, et al. Introduction of pharmaceutical expertise in a palliative care team in Sweden. Pharm World Sci. 2010; 32: 829–34.
  31. Pawłowska I, Pawłowski L, Lichodziejewska-Niermierko M. The role of a pharmacist in a hospice: a nationwide survey among hospice directors, pharmacists and physicians. European Journal of Hospital Pharmacy. 2016; 23: 106–12.
  32. Demler TL. Pharmacist Involvement in Hospice and Palliative Care. US Pharmacist. 2016; 41(3): HS2–HS5.
  33. Wilby K, Mohamad A. AlSaadi AlYafei S. Evaluation of clinical pharmacy services offered for palliative care patients in Qatar. Journal of Pain & Palliative Care Pharmacotherapy. 2014; 28: 212–5.
  34. Escutia Gutierrez R, Cortez Alvarez CR, Alvarez Alvarez RM, Flores Hernandez JL, Gutierrez Godinez J, Lopez Y Lopez JG. Pharmaceutical services in a Mexican pain relief and palliative care institute. Pharmacy Practice. 2007; 5(4): 174–8.
  35. Leverence K. What is the role of pharmacy in palliative and end-of-life care? ONS Connect [Internet]. 2015:[33 p.
  36. Naidu D, Jones K, Kanyer D, et al. Clinical pharmacist interventions as a member of palliative medicine interdisciplinary team in a community hospital. 2015 ACCP Global Conference on Clinical Pharmacy; San Francisco. : Pharmacotherapy.
  37. Mifsud I. Vella Bonanno P. Medicines management in the palliative care of patients. Journal of Malta College of Pharmacy Practice. ; 2015(21): 4–12.
  38. World Health Organization. Palliative Care: World Health Organization; 2015 Available from: http://www who int/mediacentre/factsheets/fs402/en. http://www who int/mediacentre/factsheets/fs402/en ([27/02/2017]).
  39. A working guide to international comparisons of health. Canberra: Australian Institute of Health and Welfare. ; 2012.
  40. Davari M, Khorasani E, Bakhshizade Z, et al. Ghaffari Darab M, Maracy MR. Measuring Equity in Access to Pharmaceutical Services Using Concentration Curve; Model Development. Iranian Journal of Pharmaceutical Research : IJPR. 2015; 14(4): 1317–26.
  41. The pharmacist in palliative care: Scottish Palliative Care Pharmacist's Association; 2014. http://www.nes.scot.nhs.uk/media/3204369/2015-01-12_palliative_care_distance_learning_final_copy.pdf.pdf ([11/02/2017]).
  42. Palliative Care Pharmacist's Network [11/02/2017]. Available from: http://www pcpn org uk.
  43. Society of Palliative Care Pharmacists 2017 [11/02/2017]. Available from: http://www palliativepharmacist org.
  44. ASHP. ASHP Research and Education Foundation Pain and Palliative Care Traineeship 2017. http://www.ashpfoundation.org/painmanagement ([11/02/2017]).
  45. Benefits, services, and models of subspecialty palliative care [Internet]. 2017. http://www.uptodate.com/contents/benefits-services-and-models-of-subspecialty-palliative-care - H549034695 ([cited 05/03/2017]).
  46. Meyers K, Kerr K, Cassel JB. Up Close: A field guide to community-based palliative care in California. In: Foundation CH, editor. ; 2014.
  47. Omoyeni NE, Soyannwo OA, Aikomo OO, et al. Home-based palliative care for adult cancer patients in Ibadan—a three year review. ecancermedicalscience. 2014; 8: 490.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl